Institute for Global Nutrition and Department of Nutrition, University of California, Davis, Davis, CA, USA.
Public Health Nutrition, Department of Public Health and Primary Care, University of Ghent, Ghent, Belgium.
Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):15S-42S. doi: 10.1093/ajcn/nqab278.
Meta-analyses show that small-quantity lipid-based nutrient supplements (SQ-LNSs) reduce child stunting and wasting. Identification of subgroups who benefit most from SQ-LNSs may facilitate program design.
We aimed to identify study-level and individual-level modifiers of the effect of SQ-LNSs on child growth outcomes.
We conducted a 2-stage meta-analysis of individual participant data from 14 randomized controlled trials of SQ-LNSs provided to children 6-24 mo of age (n = 37,066). We generated study-specific and subgroup estimates of SQ-LNS compared with control and pooled the estimates using fixed-effects models. We used random-effects meta-regression to examine study-level effect modifiers. In sensitivity analyses, we examined whether results differed depending on study arm inclusion criteria and types of comparisons.
SQ-LNS provision decreased stunting (length-for-age z score < -2) by 12% (relative reduction), wasting [weight-for-length (WLZ) z score < -2] by 14%, low midupper arm circumference (MUAC) (<125 mm or MUAC-for-age z score < -2) by 18%, acute malnutrition (WLZ < -2 or MUAC < 125 mm) by 14%, underweight (weight-for-age z score < -2) by 13%, and small head size (head circumference-for-age z score < -2) by 9%. Effects of SQ-LNSs generally did not differ by study-level characteristics including region, stunting burden, malaria prevalence, sanitation, water quality, duration of supplementation, frequency of contact, or average compliance with SQ-LNS. Effects of SQ-LNSs on stunting, wasting, low MUAC, and small head size were greater among girls than among boys; effects on stunting, underweight, and low MUAC were greater among later-born (than among firstborn) children; and effects on wasting and acute malnutrition were greater among children in households with improved (as opposed to unimproved) sanitation.
The positive impact of SQ-LNSs on growth is apparent across a variety of study-level contexts. Policy-makers and program planners should consider including SQ-LNSs in packages of interventions to prevent both stunting and wasting.This trial was registered at www.crd.york.ac.uk/PROSPERO as CRD42019146592.
荟萃分析表明,小剂量脂质基营养补充剂(SQ-LNS)可减少儿童发育迟缓与消瘦。明确最能从 SQ-LNS 中获益的亚组人群可能有助于方案设计。
我们旨在确定 SQ-LNS 对儿童生长结局影响的研究水平和个体水平的调节因素。
我们对 14 项 SQ-LNS 随机对照试验的个体参与者数据进行了 2 阶段荟萃分析,这些试验为 6-24 月龄儿童提供 SQ-LNS(n=37066)。我们生成了 SQ-LNS 与对照组的研究特异性和亚组估计值,并使用固定效应模型对这些估计值进行了汇总。我们使用随机效应荟萃回归来检查研究水平的效应修饰因素。在敏感性分析中,我们检查了结果是否因研究臂纳入标准和比较类型而异。
SQ-LNS 供应使发育迟缓(年龄别身长 Z 评分<-2)减少了 12%(相对减少),消瘦[身长别体重(WLZ)Z 评分<-2]减少了 14%,低中上臂围(<125mm 或上臂围年龄别 Z 评分<-2)减少了 18%,急性营养不良(WLZ<-2 或 MUAC<125mm)减少了 14%,体重不足(体重年龄别 Z 评分<-2)减少了 13%,小头畸形(头围年龄别 Z 评分<-2)减少了 9%。SQ-LNS 的效果通常不受研究水平特征的影响,包括区域、发育迟缓负担、疟疾流行率、卫生设施、水质、补充持续时间、接触频率或 SQ-LNS 的平均依从性。SQ-LNS 对女孩的发育迟缓、消瘦、低中上臂围和小头畸形的影响大于男孩;对后来出生(而非第一胎)儿童的发育迟缓、体重不足和低中上臂围的影响更大;对有改良(而非未改良)卫生设施家庭儿童的消瘦和急性营养不良的影响更大。
SQ-LNS 对生长的积极影响在各种研究水平背景下都很明显。政策制定者和规划人员应考虑将 SQ-LNS 纳入预防发育迟缓与消瘦的综合干预包中。本试验在 www.crd.york.ac.uk/PROSPERO 注册,注册号为 CRD42019146592。